Statement Regarding Judge’s Approval of Special Master’s Motion to Appoint a Special Investigator

“We support the Court’s approval of the Special Masters’ request as they believe it will assist with ‘the prompt payment of all valid claims.’ As we previously told the Court, a Special Investigator will free up valuable resources so that other claims can be processed more efficiently. “In less than 18 months, 582 claims totaling […]

September 12, 2018

“We support the Court’s approval of the Special Masters’ request as they believe it will assist with ‘the prompt payment of all valid claims.’ As we previously told the Court, a Special Investigator will free up valuable resources so that other claims can be processed more efficiently.

“In less than 18 months, 582 claims totaling more than $538 million have been approved — far exceeding the NFL’s estimates of $404 million in the first ten years of the settlement. The evidence is mounting that former players are suffering from neurocognitive ailments at rates even higher than what medical experts previously estimated. We will not allow the NFL to escape this fact and evade its settlement responsibilities by using a small number of potentially fraudulent claims to deny payment to legitimate ones.”

Related News

September 9, 2024
Seven Seeger Weiss Partners Named to 2025 Lawdragon 500 Leading Litigators in America List

Seeger Weiss is proud to announce that seven partners — Chris Seeger, Stephen Weiss, David Buchanan, Shauna Itri, Parvin Aminolroaya, Matt Pawa, and Jennifer Scullion — have been named to the 2025 Lawdragon 500 Leading Litigators in America list. This prestigious guide, first published in 2007, seeks to highlight 500 of the most distinguished litigators […]

Read More
September 6, 2024
Seeger Weiss Partner Parvin Aminolroaya Featured on CBS News Discussing Ozempic Litigation

Seeger Weiss partner Parvin Aminolroaya recently appeared on CBS News to discuss ongoing litigation against pharmaceutical companies Novo Nordisk and Eli Lilly over their popular GLP-1 receptor agonist medications such as Ozempic, Wegovy, Mounjaro, and Zepbound. Our firm represents patients across the country who allege they suffered serious medical complications while taking these drugs and […]

Read More
August 20, 2024
Seeger Weiss Partner Shauna Itri Appointed to Plaintiff’s Executive Committee in AT&T Data Breach Multidistrict Litigation

PHILADELPHIA, PA – Seeger Weiss partner Shauna Itri has been appointed to the Plaintiff’s Executive Committee in the AT&T Inc Customer Data Security Breach Litigation by the Honorable Judge Ada Brown of the Northern District of Texas, Dallas Division. This litigation consolidates dozens of class action lawsuits stemming from a data breach earlier this year, […]

Read More